Orient Paper & Industries reported a reduced net loss of ₹28.81 crore for FY26, down from ₹54.66 crore in FY25. Revenue grew 1.13% to ₹905.95 crore. The company highlights growth in value-added products like copier paper and bamboo tissue.
Orient Paper & Industries FY26 Results
Net Loss: ₹28.81 crore
Revenue from Operations: ₹905.95 crore
Reader Takeaway: Reduced losses and revenue growth, but facing pricing pressures and rising costs.
What just happened
Orient Paper & Industries reported a net loss of ₹28.81 crore for the financial year 2025-26. This marks an improvement from the ₹54.66 crore net loss in the previous fiscal year. Revenue from operations saw a marginal increase of 1.13%, reaching ₹905.95 crore for FY26 compared to ₹895.79 crore in FY25.
Why this matters
The reduction in net loss signals operational improvements and potential progress in the company's transformation strategy. Revenue growth, albeit small, combined with a significant increase in value-added product sales, indicates a shift towards more profitable segments. However, ongoing cost pressures and pricing challenges in core segments remain key concerns.
The backstory
The company has been focusing on shifting its product mix towards value-added items, such as copier paper and bamboo tissue, while implementing cost-efficiency measures through 'Project Sankalp'. This financial year's results reflect early stages of this strategy amid challenging market conditions.
What changes now
Orient Paper continues its focus on efficiency and product innovation. The positive cash flow in Q4 FY26 is a notable milestone. The company is also proceeding with capacity expansion for its tissue business.
Risks to watch
Investors should be aware of pricing pressures in the writing and printing segments, elevated raw material sourcing costs due to logistical restrictions, and significant ongoing tax disputes, particularly related to water tax.
Peer comparison
(No peer comparison data available in the provided filing.)
Context metrics (time-bound)
- Revenue from Operations: ₹905.95 crore (FY26) vs ₹895.79 crore (FY25)
- Net Loss: ₹28.81 crore (FY26) vs ₹54.66 crore (FY25)
- EBITDA: (₹20.76 crore) (FY26) vs (₹5.07 crore) (FY25)
- Copier paper sales growth: 71%
- Bamboo tissue sales growth: 238%
- Project Sankalp estimated annual savings: ₹40 crore
What to track next
Investors should monitor the execution of 'Project Sankalp' and its impact on cost savings, the competitive landscape affecting paper prices, and the progress of the new Tissue-4 machine expansion.